Advertisement
CAH vs HSIC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a Hold and HSIC is a Hold.
CAH's RSI Oscillator climbs out of oversold territory
The RSI Oscillator for CAH moved out of oversold territory on September 29, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 19 of the 22 cases the stock moved higher. This puts the odds of a move higher at 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on CAH as a result. In 57 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for CAH just turned positive on October 02, 2026. Looking at past instances where CAH's MACD turned positive, the stock continued to rise in 30 of 42 cases over the following month. The odds of a continued upward trend are 71%.
CAH moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CAH crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 83%.
Following a +0.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in 264 of 396 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.
CAH broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CAH entered a downward trend on October 08, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.077) is normal, around the industry mean (2.488). P/E Ratio (30.469) is within average values for comparable stocks, (39.020). Projected Growth (PEG Ratio) (1.105) is also within normal values, averaging (2.016). CAH has a moderately high Dividend Yield (0.009) as compared to the industry average of (0.004). P/S Ratio (0.217) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
HSIC in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 17, 2026
HSIC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 24 of 34 cases where HSIC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 71%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on HSIC as a result. In 54 of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for HSIC just turned positive on October 13, 2026. Looking at past instances where HSIC's MACD turned positive, the stock continued to rise in 27 of 46 cases over the following month. The odds of a continued upward trend are 59%.
Following a +1.21% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSIC advanced for three days, in 162 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
HSIC moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HSIC crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSIC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
The Aroon Indicator for HSIC entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. HSIC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.036) is normal, around the industry mean (2.488). P/E Ratio (25.070) is within average values for comparable stocks, (39.020). Projected Growth (PEG Ratio) (1.715) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (0.750) is also within normal values, averaging (4.260).
The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSIC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.
CAH | HSIC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 16 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 84 | |
SMR RATING 1..100 | 99 | 63 | |
PRICE GROWTH RATING 1..100 | 35 | 47 | |
P/E GROWTH RATING 1..100 | 19 | 25 | |
SEASONALITY SCORE 1..100 | n/a | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HSIC's Valuation (62) in the Medical Distributors industry is in the same range as CAH (66). This means that HSIC’s stock grew similarly to CAH’s over the last 12 months.
CAH's Profit vs Risk Rating (3) in the Medical Distributors industry is significantly better than the same rating for HSIC (84). This means that CAH’s stock grew significantly faster than HSIC’s over the last 12 months.
HSIC's SMR Rating (63) in the Medical Distributors industry is somewhat better than the same rating for CAH (99). This means that HSIC’s stock grew somewhat faster than CAH’s over the last 12 months.
CAH's Price Growth Rating (35) in the Medical Distributors industry is in the same range as HSIC (47). This means that CAH’s stock grew similarly to HSIC’s over the last 12 months.
CAH's P/E Growth Rating (19) in the Medical Distributors industry is in the same range as HSIC (25). This means that CAH’s stock grew similarly to HSIC’s over the last 12 months.
| CAH | HSIC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | N/A |
| Stochastic ODDS (%) | 2 days ago 50% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 55% |
| MACD ODDS (%) | 2 days ago 71% | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 53% |
| TrendMonth ODDS (%) | 2 days ago 65% | 2 days ago 54% |
| Advances ODDS (%) | 2 days ago 67% | 2 days ago 55% |
| Declines ODDS (%) | 22 days ago 42% | 10 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 48% | 2 days ago 71% |
| Aroon ODDS (%) | 2 days ago 43% | 2 days ago 42% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CAH’s FA Score shows that 2 FA rating(s) are green while HSIC’s FA Score has 1 green FA rating(s).
- CAH’s FA Score: 2 green, 3 red.
- HSIC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CAH’s TA Score shows that 6 TA indicator(s) are bullish while HSIC’s TA Score has 4 bullish TA indicator(s).
- CAH’s TA Score: 6 bullish, 4 bearish.
- HSIC’s TA Score: 4 bullish, 5 bearish.
Price Growth
CAH (@Medical Distributors) experienced а +2.69% price change this week, while HSIC (@Medical Distributors) price change was +0.22% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was +1.67%. For the same industry, the average monthly price growth was +3.33%, and the average quarterly price growth was -20.54%.
Reported Earning Dates
CAH is expected to report earnings on Nov 05, 2026.
HSIC is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Medical Distributors (+1.67% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IUSB | 44.19 | 0.04 | +0.09% |
| iShares Core Total USD Bond Market ETF (IUSB) | |||
| SH | 31.83 | 0.01 | +0.03% |
| ProShares Short S&P500 (SH) | |||
| GOCT | 42.95 | -0.01 | -0.02% |
| FT Vest U.S. Equity Moderate Buffer ETF - October (GOCT) | |||
| GTR | 27.43 | -0.02 | -0.07% |
| WisdomTree Target Range Fund (GTR) | |||
| GGTL | 40.38 | -0.58 | -1.42% |
| Gabelli Global Technology Leaders ETF (GGTL) | |||